Reata Pharmaceuticals has been granted a patent for biaryl amides and coumarin-based compounds with modified sugar groups for treating diseases related to the heat shock protein pathway. The compounds are effective in treating neurological disorders like neurodegenerative diseases and diabetic peripheral neuropathy. GlobalData’s report on Reata Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Reata Pharmaceuticals, NSAID cancer drugs was a key innovation area identified from patents. Reata Pharmaceuticals's grant share as of January 2024 was 78%. Grant share is based on the ratio of number of grants to total number of patents.
Biaryl amides and coumarin-based compounds for treating diseases
A recently granted patent (Publication Number: US11827664B2) discloses a compound of a specific formula, along with various defined variations of the compound. The compound is further characterized by the presence of specific substituents and functional groups, such as hydroxy and alkoxy, within the molecular structure. Additionally, the patent claims a pharmaceutical composition comprising the compound and an excipient, highlighting potential applications in the field of medicine.
The patent also includes detailed descriptions of the compound's variations, specifying different substituents and configurations that can be present in the molecular structure. For instance, the compound can have alkyl or substituted alkyl groups, with specific substitutions like OH, OCH3, F, Cl, or Br. These variations aim to enhance the compound's properties and potential uses, showcasing the innovative nature of the patented invention. Overall, the patent provides a comprehensive overview of the compound and its pharmaceutical composition, paving the way for potential developments in the healthcare industry.
To know more about GlobalData’s detailed insights on Reata Pharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
